Genomma Sets New Pricing Sights
Genomma Lab is targeting mid-week to retry a sale of up to MXP2bn ($154m) in what would be the Mexican pharmaceutical...
Already have an account?
Subscribe now for unlimited access to all current and archive news, data and market analysis.
Take a free two-week trial now for the latest news, data and market analysis.